Cytokine therapy in melanomaSULLIVAN, Ryan J; ATKINS, Michael B.Journal of cutaneous pathology. 2010, Vol 37, pp 60-67, issn 0303-6987, 8 p., SUP1Article

Resistance to BRAF-targeted therapy in melanomaSULLIVAN, Ryan J; FLAHERTY, Keith T.European journal of cancer (1990). 2013, Vol 49, Num 6, pp 1297-1304, issn 0959-8049, 8 p.Article

The Intersection of Immune-Directed and Molecularly Targeted Therapy in Advanced Melanoma: Where We Have Been, Are, and Will BeSULLIVAN, Ryan J; LORUSSO, Patricia M; FLAHERTY, Keith T et al.Clinical cancer research (Print). 2013, Vol 19, Num 19, pp 5283-5291, issn 1078-0432, 9 p.Article

HIV-associated multicentric Castleman's diseaseSTEBBING, Justin; PANTANOWITZ, Liron; DAYYANI, Farshid et al.American journal of hematology. 2008, Vol 83, Num 6, pp 498-503, issn 0361-8609, 6 p.Article

Outcomes of Patients With Metastatic Melanoma Treated With Immunotherapy Prior to or After BRAF InhibitorsACKERMAN, Allison; KLEIN, Oliver; MENZIES, Alexander M et al.Cancer. 2014, Vol 120, Num 11, pp 1695-1701, issn 0008-543X, 7 p.Article

Clinical Activity of Ipilimumab for Metastatic Uveal Melanoma: A Retrospective Review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne ExperienceLUKE, Jason J; CALLAHAN, Margaret K; FLAHERTY, Keith T et al.Cancer. 2013, Vol 119, Num 20, pp 3687-3695, issn 0008-543X, 9 p.Article

BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic MelanomaFREDERICK, Dennie T; PIRIS, Adriano; WEIYI PENG et al.Clinical cancer research (Print). 2013, Vol 19, Num 5, pp 1225-1231, issn 1078-0432, 7 p.Article

Multicentric Castleman's Disease Masquerading as HIV-Related LymphomaDAYYANI, Farshid; PANTANOWITZ, Liron; SANDRIDGE, Tom G et al.The American journal of the medical sciences. 2007, Vol 334, Num 4, pp 317-319, issn 0002-9629, 3 p.Article

Case 21-2013: A 68-Year-Old Man with Metastatic MelanomaSULLIVAN, Ryan J; LAWRENCE, Donald P; WARGO, Jennifer A et al.The New England journal of medicine. 2013, Vol 369, Num 2, pp 173-183, issn 0028-4793, 11 p.Article

Correlation of NRAS Mutations With Clinical Response to High-dose IL-2 in Patients With Advanced MelanomaJOSEPH, Richard W; SULLIVAN, Ryan J; HWU, Patrick et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 1, pp 66-72, issn 1524-9557, 7 p.Article

Characterizing the Clinical Benefit of Ipilimumab in Patients Who Progressed on High-dose IL-2JOSEPH, Richard W; ECKEL-PASSOW, Jeanette E; ATKINS, Michael B et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 9, pp 711-715, issn 1524-9557, 5 p.Article

Epidemiology, Pathophysiology, and Treatment of Kaposi Sarcoma-Associated Herpesvirus Disease : Kaposi Sarcoma, Primary Effusion Lymphoma, and Multicentric Castleman DiseaseSULLIVAN, Ryan J; PANTANOWITZ, Liron; CASPER, Corey et al.Clinical infectious diseases. 2008, Vol 47, Num 9, pp 1209-1215, issn 1058-4838, 7 p.Article